Sequel Pharmaceuticals, Inc
3 clinical trials · Sponsor
◉ Watch Sequel Pharmaceuticals, Inc
| Record | Firm | Date |
|---|---|---|
| Effects of Intravenous K201 on the Restoration of Sinus Rhythm in Subjects With Symptomatic Atrial Fibrillation (NCT01259622) | Sequel Pharmaceuticals, Inc | 2011-02-01 |
| Phase 2 Study of Oral K201 for Prevention of AF Recurrence (NCT01067833) | Sequel Pharmaceuticals, Inc | 2010-04-01 |
| Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation (NCT00626652) | Sequel Pharmaceuticals, Inc | 2008-03-01 |
Track Sequel Pharmaceuticals, Inc automatically
Every clearance here is in the API, with alerts when new ones post.